LncRNA HOXC-AS3 increases non-small cell lung cancer cell migration and invasion by sponging premature miR-96
出版年份 2022 全文链接
标题
LncRNA HOXC-AS3 increases non-small cell lung cancer cell migration and invasion by sponging premature miR-96
作者
关键词
-
出版物
Expert Review of Respiratory Medicine
Volume -, Issue -, Pages 1-7
出版商
Informa UK Limited
发表日期
2022-01-16
DOI
10.1080/17476348.2022.2030223
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance
- (2021) Rana Shafabakhsh et al. CANCER GENE THERAPY
- Exosomes and Lung cancer: Roles in pathophysiology, diagnosis and therapeutic applications
- (2020) Atefeh Amiri et al. CURRENT MEDICINAL CHEMISTRY
- Therapeutic potentials of curcumin in the treatment of non‐small‐cell lung carcinoma
- (2020) Mahsa Salehi et al. PHYTOTHERAPY RESEARCH
- Non-coding RNAs and exosomes: their role in the pathogenesis of sepsis
- (2020) Seyed MohammadReza Hashemian et al. Molecular Therapy-Nucleic Acids
- Autophagy-related MicroRNAs in chronic lung diseases and lung cancer
- (2020) Samaneh Rezaei et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Regulation of glycolysis by non-coding RNAs in cancer: Switching on the Warburg effect
- (2020) Hamed Mirzaei et al. Molecular Therapy-Oncolytics
- Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles
- (2020) Zahra Sadat Razavi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Long Non-Coding RNAs: Epigenetic Regulators in Cancer
- (2019) Asma Vafadar et al. CURRENT PHARMACEUTICAL DESIGN
- A Novel lncRNA HOXC-AS3 Acts as a miR-3922-5p Sponge to Promote Breast Cancer Metastasis
- (2019) Sheng-Hong Shi et al. CANCER INVESTIGATION
- Smoking, Sex, and Non–Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424)
- (2018) Ting-Yuan David Cheng et al. JNCI-Journal of the National Cancer Institute
- Smoking, Sex, and Non–Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424)
- (2018) Ting-Yuan David Cheng et al. JNCI-Journal of the National Cancer Institute
- Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance
- (2018) Zachary Schrank et al. Cancers
- Location of stage I-III non-small cell lung cancer and survival rate: Systematic review and meta-analysis
- (2018) Hyun Woo Lee et al. Thoracic Cancer
- Molecular aspects of pancreatic β-cell dysfunction: Oxidative stress, microRNA, and long noncoding RNA
- (2018) Mohammad Javad Saeedi Borujeni et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non–Small Cell Lung Cancer
- (2018) Jose M. Pacheco et al. Journal of Thoracic Oncology
- Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2017) Nasser Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- (2017) Mariam Jamal-Hanjani et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
- (2017) David P. Carbone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
- (2017) Yong Tang et al. OncoTargets and Therapy
- lncRNAs and microRNAs with a role in cancer development
- (2016) Julia Liz et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC)
- (2015) Nesaretnam Barr Kumarakulasinghe et al. RESPIROLOGY
- miR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells
- (2014) Haizhou Guo et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer
- (2010) S. Yu et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started